Verified email-pattern data for Ophtai is currently limited. You can still use the company insights and contact sections below.
OphtAI, an Artificial Intelligence which, by analysing retina fundus photos in a few seconds, is able to detect early signs of Diabetic Retinopathy as well as the risk of Glaucoma or AMD.
425 million diabetics in the world, forecast to grow up to 600 million in 2035. ~30% of them would have diabetic retinopathy. This retina disease is the 1st cause of blindness in people under 60 years old.
Hence, its screening is a public health issue and must be systematic: the WHO recommends if for all diabetics once a year. OphtAI answers a public healthcare need and aims for massive-automated eye disease screening. It meets a major challenge: the management of all patients at risk of eye disease and, therefore, eye care organization optimization.
Ophthalmologists practicing fundus with pupil dilation cannot be the only solution for this. A first line that will sort out patients at risk and send only them for being managed is needed. This increases screening capacity while saving medical time. Different organizations are possible depending on local state regulations. Operators who take retinal photos with a non-mydriatic retinograph screens themselves or send photos for remote interpretation. In both cases, OphtAI use allows for photo quality control, lesion mapping, pathology severity level assessment and recommends the course of action to take.
This can be accessed directly on the Internet using the my.ophtAI.com website or integrated into our partners' software packages and instruments.
Our service, which is a CE Cat IIa medical device, guarantees the same screening quality as the best retinologists and can therefore be used by non-experts during patient consultation. It was developed in partnership with the Paris Hospitals (AP-HP), France's largest screening network, and an INSERM research laboratory specialized in AI. The -already patented- next version of OphtAI will be able to detect some 40 pathological signs and symptoms in the general population
Company Details
- Employees
- 3
- Founded
- -
- Address
- Paris, Île-De-France, Fr
- Industry
- Software Development
- Website
- ophtai.com
- Keywords
- Bordeaux.
- HQ
- Paris, Île-de-France
Ophtai Questions
OphtAI's website is ophtai.com
OphtAI's LinkedIn profile is https://fr.linkedin.com/company/ophtai
OphtAI has
3 employees.
View email and phone details for 3
employees at OphtAI.
OphtAI's industry is
Software Development
OphtAI's top competitors are
Primaa,
Posos,
Pixyl,
Gleamer,
Synapse Medicine,
Volta Medical,
Altris Ai,
Milvue,
Evolucare,
Paperdoc.
OphtAI's categories are Software Development
OphtAI's founding year is 2019
Companies like OphtAI
Top OphtAI Employees
-
Melanie FOLTETE
Assistante Commerciale Chez Adcis -…
Saint-Contest, Normandy, France, France2adcis.net, adcis.net -
Alexandre LE GUILCHER
Innovation Director Evolucare- Ceo…
Montesson, Île-De-France, France, France2ophtai.com, evolucare.com
Free Chrome Extension
Find emails, phones & company data instantly
Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Aero Online
Your AI prospecting assistant
Select data to include:
Total price:
$0.00
0 records × $0.02 per record
How It Works
Get a Free Account
Sign up for a free account. No credit card required. Up to 10 free credits.
Search the #1 Contact Database
Get contact details of over 750M+ profiles across 60M companies – all with industry-leading accuracy. Sales Navigator and Recruiter users, try out our Email Finder Extension.
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.